These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 22608274)

  • 41. Drug therapy in pediatric cardiology and the role of digoxin in pediatric congestive heart failure.
    Abdulla RI
    Pediatr Cardiol; 2004; 25(6):621. PubMed ID: 15793623
    [No Abstract]   [Full Text] [Related]  

  • 42. The role of the pharmacy coordinating center in the DIG trial.
    Fye CL; Gagne WH; Raisch DW; Jones MS; Sather MR; Buchanan SL; Chacon FR; Garg R; Yusuf S; Williford WO;
    Control Clin Trials; 2003 Dec; 24(6 Suppl):289S-297S. PubMed ID: 14643075
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Digoxin for the treatment of heart failure.
    Moulias S; Tigoulet F; Meaume S
    N Engl J Med; 2003 Feb; 348(7):661-3; author reply 661-3. PubMed ID: 12584380
    [No Abstract]   [Full Text] [Related]  

  • 44. Digoxin therapy for heart failure: an update.
    Morris SA; Hatcher HF; Reddy DK
    Am Fam Physician; 2006 Aug; 74(4):613-8. PubMed ID: 16939183
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Digoxin for the treatment of heart failure.
    Hudson M; Pilote L
    N Engl J Med; 2003 Feb; 348(7):661-3; author reply 661-3. PubMed ID: 12587574
    [No Abstract]   [Full Text] [Related]  

  • 46. Digoxin for the treatment of heart failure.
    Hallberg P; Michaëlsson K; Melhus H
    N Engl J Med; 2003 Feb; 348(7):661-3; author reply 661-3. PubMed ID: 12587575
    [No Abstract]   [Full Text] [Related]  

  • 47. Drug therapy of chronic heart failure in the elderly: the current state of clinical-trial evidence.
    Dulin BR; Krum H
    Curr Opin Cardiol; 2006 Jul; 21(4):393-9. PubMed ID: 16755210
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rationale and design of the enoximone clinical trials program.
    Lowes BD; Shakar SF; Metra M; Feldman AM; Eichhorn E; Freytag JW; Gerber MJ; Liard JF; Hartman C; Gorczynski R; Evans G; Linseman JV; Stewart J; Robertson AD; Roecker EB; Demets DL; Bristow MR
    J Card Fail; 2005 Dec; 11(9):659-69. PubMed ID: 16360960
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of heart failure with preserved systolic function.
    de Groote P; Herpin D; Diévart F; Hanon O; Trochu JN; Artigou JY; Galinier M; Habib G; Juillière Y; Neuder Y; Roudaut R; Komajda M
    Arch Cardiovasc Dis; 2008 May; 101(5):361-72. PubMed ID: 18656095
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Digoxin in the treatment of patients with chronic heart failure. Its place in therapy.
    Uretsky BF
    Drugs Aging; 1995 Jul; 7(1):1-9. PubMed ID: 7579776
    [No Abstract]   [Full Text] [Related]  

  • 51. Use of digoxin for heart failure and atrial fibrillation in elderly patients.
    Cheng JW; Rybak I
    Am J Geriatr Pharmacother; 2010 Oct; 8(5):419-27. PubMed ID: 21335295
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Digoxin in reduced heart failure and sinus rhythm. When should it be indicated in 2018?].
    Formiga F; Ariza A
    Rev Esp Geriatr Gerontol; 2018; 53(3):119-120. PubMed ID: 29598972
    [No Abstract]   [Full Text] [Related]  

  • 53. Digoxin in patients with heart failure.
    Zoneraich S
    N Engl J Med; 1997 Jul; 337(2):130; author reply 130-1. PubMed ID: 9221340
    [No Abstract]   [Full Text] [Related]  

  • 54. Rehabilitating digoxin.
    Brophy JM
    Eur Heart J; 2006 Jan; 27(2):127-9. PubMed ID: 16339158
    [No Abstract]   [Full Text] [Related]  

  • 55. Digoxin in heart failure.
    Spencer AP
    Crit Care Nurs Clin North Am; 2003 Dec; 15(4):447-52. PubMed ID: 14717389
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Pharmacotherapy of patients with chronic heart failure. Analysis of multicenter international studies].
    Chekman IS
    Lik Sprava; 2008; (1-2):60-6. PubMed ID: 18822845
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sex-based differences in the effect of digoxin for the treatment of heart failure.
    Rathore SS; Wang Y; Krumholz HM
    N Engl J Med; 2002 Oct; 347(18):1403-11. PubMed ID: 12409542
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Digoxin therapy: A persisting interest despite contrary winds.
    Juillière Y; Selton-Suty C
    Arch Cardiovasc Dis; 2010 May; 103(5):281-4. PubMed ID: 20619237
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The underuse of digoxin in heart failure, and approaches to appropriate use.
    Ahmed A; Young JB; Gheorghiade M
    CMAJ; 2007 Feb; 176(5):641-3. PubMed ID: 17325329
    [No Abstract]   [Full Text] [Related]  

  • 60. [Positive inotropic agents in heart failure. Clinico-pharmacological evidence for medical practice].
    Rohde LE; Ribeiro JP
    Arq Bras Cardiol; 1994 Dec; 63(6):537-42. PubMed ID: 7605243
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.